Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
HEMATOLOGY EXAM 2025 UPDATED VERIFIED QUESTIONS WITH CORRECT ANSWERS
Typology: Exams
1 / 41
set of plasmas with known values. This exercise is known as:
variable assay: b. Proficiency testing
the overall efficacy of an assay
predictive value: a. Area under the curve
b. Analytical quality control c. Postanalytical quality assurance d. External quality assurance: c. Postanalytical quality assurance
d. External quality assurance: b. Preanalytical quality assurance
Colorado Association for Continuing Medical Laboratory Education (CACMLE)
accreditation? a. Clinical Laboratory Improvement Advisory Committee (CLIAC) b. Centers for Medicare and Medicaid Services (CMS) c. College of American Pathologists (CAP) d. Joint Commission: c. College of American Pathologists (CAP
Disease or Condition Affected by Disease or Condition Assay is negative 40 Affected by Disease or Condition Assay os negative 5 Unaffected by Disease or Condition Assay is positive 10 Affected by Disease or Condition Assay is positive 45 What is the number of false-negative results? a. 40
c. 5 d. 45: c. 5
values for several complete blood count analytes. What is this specimen called? a. Normal
specimenb. Calibrator
prothrombin time for plasma aliquots from 15 healthy males and 15 healthy females. She computes the mean and 95.5 % confidence interval and notes that they duplicate the manufacturer's statistics within 5 %. This procedure is known as : c. Determining the therapeutic range d. Establishing the reference interval by transference: d. Establishing the reference interval by transference
references. What FDA category is this assay? a. Cleared b. Home - brew c. Research use only d. Analyte - specific reagent: d
. Analyte - specific reagent
the specimen matrix is called : a. Analytical specificity b
. Analytical sensitivity c. Clinical specificity d. Clinical sensitivity: a. Analytical specificity
is the 95.5 % confidence interval? a. 3000 to 9000 / mL b. 5400 to 6600 / mL c. 5500 to 6500 / mL d. 5700 to 6300 / mL: b. 5400 to 6600 / mL
times and produces the following five results : 12.0 g / dL 12.3 g / dL 12.0 g / dL 12.2 g / dL 12.1 g dL These results are : a. Accurate but not precise b. Precise but not accurate c. Both accurate and precise d. Neither accurate nor precise: b. Precise but not accurate
ANOVA d. Pearson: b. Student's t - test
a. Blood b. Cerebrospinal fluid c Semen d Concentrated: d Concentrated acids
a Wearing masks during patient contact b. Proper hand washing c Wearing disposable laboratory coats d Identifying specimens from known or suspect- ed HIV and HBV infected patients with a red label: b Proper hand washing
a.1 : 2 b. 1 : 5 c. 1:10 d 1 100: c 1:
c. Quarterly d. Annually: c. Quarterly
safety can or storage cabinet away from heat sources b Under a hood and arranged alphabetically for ease of identification in an emergency c In a refrigerator at 28 C to 88 C to reduce volatilization d. On a low shelf in an area protected from light: a. In an approved safety can or storage cabinet away from heat sources
a. Patient movement during venipuncture b. Improper disposal of phlebotomy equipment c. Inattention during removal of needle after venipuncture d. Failure to attach needle firmly to syringe or tube holder: b. Improper disposal of phlebotomy equipment
whether she needs to be concerned about working with a given reagent d. During a safety inspection, an aged microscope power supply is found to have a frayed power cord: c. A pregnant laboratory employee has asked whether she needs to be concerned about working with a given reagent
, and there was a major auto accident that has one staff member tied up in the blood bank all evening. Mary , the medical laboratory scientist covering hematology , is in a hurry to get a stat sample on the analyzer but needs to pour off an aliquot for another department. She is wearing gloves and a lab coat She carefully covers the stopper of the well - mixed ethylenediaminetetraacetic acid ( EDTA ) tube with a gauze square and tilts the stopper toward her so it opens away from her She pours off about 1 mL into a prelabeled tube replaces the stopper of the EDTA tube , and puts it in the sample rack and sets it on the conveyor She then brings the poured sample off to the other department How would you assess Mary's safety practice?
. Mary was careful and followed all appropriate procedures. b. Mary should have us: b. Mary should have used a shield when opening the tube.
Class A b. Class B c. Class C d. Class D: b. Class B
resistant b. Made of cloth fabric that can be readily laundered c. Long - sleeved d. Worn fully buttoned: b. Made of cloth fabric that can be readily laundered
analysis b. Risk assessment of potential safety hazards c. Mechanism for reporting accidents d.
personal equipment: d. Budget for engineering controls and personal protective equipment
gloves b. Positively identifying the patient c. Cleansing the site for the venipuncture d. Bandaging the venipuncture site: a. Wearing gloves
gauge b. One inch , 21 gauge c One - half inch , 23 gauge d. One - half inch , 25 gauge: b. One inch , 21 gauge
, the phlebotomist collected blood into lavender stopper and green stopper tubes Are these specimens acceptable? a Yes , EDTA is used for hematologic testing and heparin is used for coagulation testing. b No , although EDTA is used for hematologic testing , citrate , not heparin , is used for coagulation testing c. No , although heparin is used for hematologic testing citrate , not EDTA , is used for coagulation testing. d
. No , hematologic testing requires citrate and coagulation testing requires a clot so neither tube is acceptable: b. No , although EDTA is used for hematologic testing citrate , not heparin , is used for coagulation testing.
prominent vein in the antecubital fossa b. Cephalic or accessory cephalic , because it is the least painful site. Median or median cubital , because it has the lowest risk of damaging nerves in the arm d. One of the hand veins , because they are most superficial and easily accessed: c Median or median cubital , because it has the lowest risk of damaging nerves in the arm
c. Selecting the proper needle length d. Using the correct evacuated tube: b. Identifying the patient
angle of insertion between 15 and 30 degrees b. Up and an angle of insertion less than 30 degrees c. Down and an angle of insertion greater than 45 degrees d. Up and an angle of insertion between 30 and 45 degrees: b. Up and an angle of insertion less than 30 degrees
Incorrect needle positioning b. Tying the tourniquet too tightly c. Inadequate vacuum in the tube d. Collapsed vein: b. Tying the tourniquet too tightly
separator , nonadditive , coagulation , and blood culture b. Additive , nonadditive gel separator , and blood culture c. Nonadditive , blood culture , coagulation , and other additives d. Blood culture , coagulation , nonadditive , and gel separator or other additives: d. Blood culture coagulation nonadditive , and gel separator or other additives
of the heel b. Lateral or medial plantar surface of the heel c. Plantar surface of the heel close to the arch of the foot d. Middle of the plantar surface of the heel: b. Lateral or medial plantar surface of the heel
Dilute the blood before testing c. Prevent the blood from clotting d. Ensure the sterility of the tube: c
. Prevent the blood from clotting
Specimen collected for blood cortisol in the morning c. Specimen in lavender stopper tube grossly hemolyzed d. Room number is missing from the specimen tube label: c. Specimen in lavender
stopper tube grossly hemolyzed
to obtain written consent for phlebotomy c. Entering a patient's room when the family is present d. Asking an outpatient for his or her full name in the process of identification: a. Breach of patient confidentiality
field to be in focus , whereas the periphery is blurred ? a. Plan achromatic b. Achromatic c. Plan apochromatic d. Flat field: b. Achromatic
Eyepiece b. Objective lens c. Condenser d. Optical tube: c. Condenser
a 103 objective. The specimen remains in focus at
apochromatic c. Bichromatic d. Plan achromatic: b. Plan apochromatic
a. Condenser is first adjusted to its lowest position b. Height of the condenser is adjusted by removing the eyepiece c. Image of the field diaphragm iris is used to center the condenser d Closing the aperture diaphragm increases the resolution the image: c. Image of the field diaphragm iris is used to center the condenser
13 b. 103 c. 1003 d. 10003: c. 1003
viewed with an oil immersion objective lens , light intensity should never be regulated by adjusting the : a. Rheostat b. Neutral density filter c. Light control knob d. Condenser: d. Condenser
Xylene c. Water d. Benzene: a. 70 % alcohol or lens cleaner
double refractive? a. Compound brightfieldb. Darkfield c. Polarizing d. Phase-contrast: c. Polarizing
find a suitable portion of the slide for examination
. He moves the 103 objectives out of place , places a drop of oil on the slide , rotates the nosepiece so that the 403 objective passes through the viewing position , and continues to rotate the 1003 oil objective into viewing position . This practice should be corrected in which way? a. The stage of a parfocal microscope should be lowered before the objectives are rotated. b. The 1003 oil objective should be in place for viewing before the oil is added c. The drop of oil should be in place and the 1003 objective lowered into the oil , rather than swinging the objective into the drop. d. The objectives should be rotated in the opposite direction so that the 403 objectives does not risk entering the oil .: d. The objectives should be rotated in the opposite direction so that the 403 objectives does not risk entering the oil
, one above and the other below the condenser b. Angling the light at the specimen so that it misses the objective unless something in the specimen bends it backward c. Closing the condenser
diaphragm entirely , limiting light to just a tiny ray in the center of the otherwise dark field d. Using a light source above the specimen and collecting light reflected from the specimen , rather than transmitted through the specimen , so that when there is no specimen in place , the field is dark: b. Angling the light at the specimen so that it misses the objective unless something in the specimen bends it backward
reference method b. Test for assay precision c. Test for assay linearity d. All of the above: d. All of the above
distributor's published calibrator results. The slope is 0.99 and the y intercept is 110 %. What type of error is present? a. No error b. Random error c. Constant systematic error d. Proportional systematic error: c. Constant systematic error
d. Rough endoplasmic reticulum: b. Golgi apparatus
b. Glycoproteins and glycolipids c. Transmembrane and cytoskeletal proteins d. Rough and smooth endoplasmic reticulum: b. Glycoproteins and glycolipids
a. Nucleus b. Cytoplasm c. Membrane d. Microtubular system: a. Nucleus
b. DNA c. Ribosomes d. Glycoproteins: b. DNA
b. Mitochondria c. Ribosomes: c. Ribosomes
b. Spindle fibers c. Ribosomes d. Centrioles: a. Microtubules
c. Maintenance of electrochemical gradients d. Lipid production and oxidation: d. Lipid production and oxidation
d. Mitochondrion: d. Mitochondrion
Attachment site for centrioles: b. Transcriptionally active DNA
d. Growth factors: a. Cyclins and CDKs
a. Cyclin B/CDK1 complex b. Cyclin A/CDK2 complex c. Cyclin D d. Cyclin E/CDK2 complex: d. Cyclin E/CDK2 complex
b. Nuclear condensation c. Rupture of the cytoplasm d. Rupture of the nucle- us: b. Nuclear condensation
a. Stromal cells and growth factors b. Hematopoietic stem cells c. Liver and spleen d. Cyclins and caspases: a. Stromal cells and growth factors
Hematopoiesis b. Hematemesis c. Hematocytometry d. Hematorrhea: a. Hematopoiesis
the:
a. Bone marrow b. Spleen c. Lymph nodes d. Liver: d. Liver
regulation of their expression of CD4 and CD8? a. Spleen b. Liver c. Thymus d. Bone marrow: c. Thymus
a. Iliac crest b. Femur c. Distal radius d. Tibia: a. Iliac crest
b. Apoptosis c. Aneurysm d. Apohematics: b. Apoptosis
b. Thymus c. Spleen d. Bone marrow: c. Spleen
chromatin d. Appearance of nucleoli: c. Condensation of nuclear chromatin
with kidney disease? a. EPOb. TPO c. G-CSF d. KIT ligand: a. EPO
hematopoietic stem cell?
blood cells to meet the increased demand, one of the body's responses is: a. Extramedullary hematopoiesis in the liver and spleen b. Decreased production of erythropoietin by the kidney c. Increased apoptosis of erythrocyte progenitor cells d. Increase the proportion of yellow marrow in the long bones: a. Extramedullary hematopoiesis in the liver and spleen
lifetime of an individual because they:
numbers in the bone marrow niches d. Have a low mitotic potential in response to growth factors: b. Have the ability of self-renewal by asymmetric division
d. Orthochromic normoblast: c. CFU-E
b. Basophilic normoblast c. Pronormoblast d. Polychromatic normoblast: a. Orthochromic normoblast
other normoblasts, with an N:C ratio of nearly 1:1. The nuclear chromatin is condensed and chunky throughout the nucleus. No nucleoli are seen. The cytoplasm is a muddy, blue-pink color. a. Reticulocyte
for marrow egress c. The time between mitoses of normoblasts d. The production of antiapoptotic molecules by erythroid progenitors: b. The formation of pores in sinusoidal endothelial cells for marrow egress
erythroid lineage
the production of fibronectin by macrophages of the bone marrow: b. Stimulating EPO production by the kidney
Adjacent to megakaryocytes along the adventitial cell lining c. Surrounding fat cells in apoptotic islands d. Surrounding macrophages in erythroid islands: d. Surrounding macrophages in erythroid islands
cells.
RBCs mature.
of free cells.
occurs: a. Maturing normoblasts slowly lose receptors for adhesive molecules that bind them to stromal cells
a. Loss of mitochondria b. Increased flexibility of the cell membrane c. Reduc- tion of hemoglobin iron d. Loss of the nucleus: d. Loss of the nucleus
a. True b. False: a. True
extravasate from the blood vessels into the tissues c. Splenic macrophages ingest senescent cells d. Erythrocytes are trapped in blood clots outside the blood vessels: c. Splenic macrophages ingest senescent cells
erythron.
is composed of nucleus. c. The proportions of cytoplasm and nucleus are roughly equal: b. The bulk of the cell is composed of nucleus
Maintaining cytoplasm cationic electrochemical gradients: a. Oxygen transport
a. Hexose monophosphate pathway b. Rapoport-Luebering pathway c. Emb- den-Meyerhof pathway d. 2,3-BPG pathway: c. Embden-Meyerhof pathway
Enhances O2 release from hemoglobin c. Source of RBC glucose d. Source of RBC ATP: b. Enhances O2 release from hemoglobin
product(s) accomplishes detoxification?
glutathione
b. Cytoskeletal proteins c. GPI anchor d. Glycocalyx: 5. Which of the following helps maintain RBC shape? a. Membrane phospholipids b. Cytoskeletal proteins c. GPI anchor d. Glycocalyx
b. Carry RBC antigens. c. Constitute ion channels. d. Attach the cytoskeleton to the lipid layer: b. Carry RBC antigens.
b. In chains beneath a protein exoskeleton. c. In two layers whose composition is asymmetric. d. So that hydrophobic portions are facing the plasma: c. In two layers whose composition is asymmetric
b. Mitochondria. c. Cytoplasm. d. EMB pathway: a. Plasma
mechanisms. What portion of the Embden-Meyerhof pathway reduces iron to the physiologic 12 valence state? a. Methemoglobin reductase pathway b. Hexose monophosphate pathway c. Rapoport-Luebering pathway d. The 2,3-BPG shunt: a. Methemoglobin reduc- tase pathway
a. Glycophorin A b. Ankyrin c. Spectrin d. Actin: a. Glycophorin A
RBC membrane proteins may be seen as:
pathway deficiencies: a. Shape changes
b. Ferrous iron, protoporphyrin IX, and a globin chain c. Protoporphyrin IX and four globin chains d. Four heme molecules and four globin chains: d. Four heme molecules and four globin chains
Aminolevulinate synthase
b. Carbonic anhydrase c. Protoporphyrin IX reductase d. Glucose 6-phosphate dehydrogenase: a. Aminolevulinate synthase
a. Tense b. Relaxed: a. Tense
predict the position of the curve when there is a decrease in pH.
increased oxygen affinity d. Shifted to the left of normal with decreased oxygen affinity: a. Shifted to the right of normal with decreased oxygen affinity
a. Gower-1 b. Gower- c. A d. F: d. F
a. 80% to 90% Hb A, 5% to 10% Hb A2, 1% to 5% Hb F b. 80% to 90% Hb A2, 5% to 10% Hb A, 1% to 5% Hb F c. .95% Hb A, ,3.5% Hb A2, 1% to 2% Hb F d. .90% Hb A, 5% Hb F, ,5% Hb A2: c. .95% Hb A, ,3.5% Hb A2, 1% to 2% Hb F
structure d. Hemoglobin carrying carbon monoxide; hence "oxidized" refers to the single oxygen: b. Hemoglobin with iron in the ferric state (methemoglobin) and not able to carry oxygen
a. a tetramer in some cells and b tetramers in othersb. A mixture of a tetramers and b tetramers c. a dimers and b dimers d. Two ab dimers: d. Two ab dimers
chromosome, including two a gene and two b genes
and one b gene on a different chromosome
and two b genes on a different chromosome: b. With a genes and b genes on separate chromosomes, including two a genes on one chromosome and one b gene on a different chromosome
a. Binds to the heme moiety, blocking the binding of oxygen b. Binds simulta- neously with oxygen to ensure that it stays bound until it reaches the tissues, when both molecules are released from hemoglobin c. Binds to amino acids of the globin chain, contributing to a conformational change that inhibits oxygen from binding to heme d. Oxidizes hemoglobin iron, diminishing oxygen binding and promoting oxy- gen delivery to the tissues: c. Binds to amino acids of the globin chain, contributing to a conformational change that inhibits oxygen from binding to heme
b. Ferritin c. Transferrin d. Hemoglobin: d. Hemoglobin
d. Hemoglobin: b. Ferritin
which iron-related protein? a. Hemosiderin b. Ferritin c. Transferrin d. Hemoglobin: c. Transferrin
the following tests would be most helpful in determining whether iron deficiency is present or not? a. Zinc protoporphyrin b. Peripheral blood sideroblast assessment c. Soluble transferrin receptor d. Mean cell hemoglobin: c. Soluble transferrin receptor
lumen into the enterocyte? a. Transferrin b. Ferroportin c. DMT1 d. Ferrochelatase: c. DMT1
protein? a. Transferrin b. Ferroportin c. DMT1 d. Ferrochelatase: b. Ferroportin
to incorporation into heme. Place them in proper order. i. Transferrin picks up ferric iron. ii. Iron is transferred to the mitochondria. iii. DMT1 transports ferrous iron into the enterocyte. iv. Ferroportin transports iron from enterocyte to plasma. v. The transferrin receptor transports iron into the cell. a. v, iv, i, ii, iii b. iii, ii, iv, i, v c. ii, i, v, iii, iv d. iii, iv, i, v, ii: d. iii, iv, i, v, ii
iron to a cell? a. It is recycled to the plasma membrane and released into the plasma.
membrane, where it can bind its ligand again
a. Transferrin b. Ferroportin c. Hephaestin d. Hepcidin: d. Hepcidin
and TIBC of 420 mg/dL? a. 6.7% b. 12% c. 15% d. 80%: c. 15%
fall with the following test results: Soluble transferrin receptor: increased above reference interval Ferritin: decreased below reference interval Hemoglobin content of reticulo- cytes: within the reference interval
Normal iron status b. Latent iron deficiency c. Functional iron deficiency d. Iron deficiency
intestinal bleeding due to aspirin use for rheumatoid arthritis.
The iron studies on the patient show the following results SERUM FERRITIN LEVEL 12-400 ng/mL 25 ng/mL SERUM IRON LEVEL 50-160 mg/dL 45 mg/dL TOTAL IRON INDING CAPACITY (TIBC) 250-400 mg/dL 405 mg/dL TRANSFERRIN SATURATION 20%- 55% CALCULATE IT How would these results be interpreted? a. Latent iron deficiency
d. Equivocal for iron deficiency: d. Equivocal for iron deficiency
a. CLP b. GMP c. MEP d. HSC: b. GMP
shape and the cytoplasm has secondary granules that are lavender in color is the: a. Band b. Myelocyte c. Promyelocyte d. Metamyelocyte: d. Metamyelocyte